Finance

Beta
Lists
FAE:BME
FAES Farma SA
€4.54
+0.22%
(+0.0100) 1D
Jun 3, 5:36:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for FAE...
Open
€4.52
High
€4.54
Low
€4.49
Mkt. cap
1.43B
Avg. vol.
135.62K
Volume
67.87K
P/E ratio
17.24
52-wk high
€5.44
52-wk low
€4.10
EPS
€0.26
Shares outstanding
316.22M
No. of employees
3K
Open
€4.52
High
€4.54
Low
€4.49
Mkt. cap
1.43B
Avg. vol.
135.62K
Volume
67.87K
P/E ratio
17.24
52-wk high
€5.44
52-wk low
€4.10
EPS
€0.26
Shares outstanding
316.22M
No. of employees
3K
News stories
From sources across the web
Profile
Faes Farma, originally Fábrica Española de Productos Químicos y Farmacéuticos, is a Spanish pharmaceutical company based in the Lamiaco district of Lejona in Biscay. Founded on 29 July 1933 by the Serra family with an initial capital of two million pesetas, it pioneered the development of various therapeutic compounds and has been listed on the Madrid Stock Exchange since the 1940s. Faes Farma’s headquarters, production facilities, and R&D center are located in Lejona, with additional offices in Madrid and Barcelona. The group also operates subsidiaries in Portugal, Italy, Mexico, Guatemala, Colombia, Chile, Peru, Bolivia, Ecuador and Nigeria, and maintains an animal nutrition and health division under the name FARM Faes. Wikipedia
About FAES Farma SA
CEO-
Employees2.68K
FoundedJul 29, 1933
Headquarters-
SectorPharmaceutical industry
Last report
Apr 30, 2026
Fiscal period
Q1 2026
EPS / Est. (EUR)
- / -
Revenue / Est. (EUR)
200.07M / 192.23M
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
154.39M
146.61M
172.99M
200.07M
Cost of goods sold
52.56M
52.40M
73.44M
61.59M
Cost of revenue
52.56M
52.40M
73.44M
61.59M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31.26M
27.36M
80.84M
45.67M
Operating expense
73.74M
68.06M
98.44M
100.13M
Total operating expenses
126.30M
120.47M
171.88M
161.72M
Operating income
28.09M
26.14M
1.11M
38.35M
Other non operating income
377.26M
401.00K
1.02M
-
EBT including unusual items
27.76M
25.18M
-1.39M
36.36M
EBT excluding unusual items
207.84M
25.18M
-1.65M
36.36M
Income tax expense
3.95M
3.75M
-7.43M
5.49M
Effective tax rate
14.22%
14.91%
534.46%
15.10%
Other operating expenses
36.51M
33.65M
7.21M
44.62M
Net income
23.96M
21.23M
6.07M
30.79M
Net profit margin
15.52%
14.48%
3.51%
15.39%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-196.88M
-1.99M
-3.51M
-1.99M
Net interest expenses
-196.88M
-1.99M
-3.51M
-1.99M
Depreciation and amortization charges
5.98M
7.05M
10.39M
9.83M
EBITDA
32.84M
30.15M
6.94M
44.19M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more